What's Happening?
A comprehensive review published in The BMJ has identified the most effective treatments for bipolar disorder across various age groups and mood phases. The study, involving 77 meta-analyses and 116 treatments, was conducted by an international team of
researchers. They have developed an open-access web platform to present the impact, side effects, and evidence strength for each treatment. This platform aims to assist clinicians and patients in making informed treatment decisions, promoting shared decision-making and personalized care.
Why It's Important?
Bipolar disorder affects millions worldwide, with less than half finding effective treatment. This review provides a valuable resource for clinicians and patients, offering a comprehensive overview of treatment options. By incorporating patient preferences and promoting shared decision-making, the platform can help find treatments that better fit individual needs, potentially improving adherence and outcomes. The review's findings have already influenced updates to international treatment guidelines, highlighting its significance in advancing mental health care.
What's Next?
The research team plans to use the platform in clinical education and assess its real-world impact on treatment effectiveness, safety, and healthcare utilization. Future projects include reviews of treatments for other mental health disorders, aiming to continuously improve care through updated evidence. This approach could revolutionize how mental health guidelines are developed and implemented, ensuring they remain current and relevant.
